These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 33964540)

  • 1. Long-term safety, efficacy, and tolerability of levetiracetam in pediatric patients with epilepsy in Uygur, China: A retrospective analysis.
    Zhao T; Li HJ; Yu J; Wang TT; Feng J; Ma L; Sun L; Sun Y; Yu LH
    Epilepsy Behav; 2021 Jul; 120():108010. PubMed ID: 33964540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety, efficacy, and tolerability of lacosamide for the treatment of epilepsy in pediatric patients in Uygur, China.
    Zhao T; Li HJ; Ma L; Feng J; Wang TT; Yu J; Sun L; Sun Y; Yu LH
    Epilepsy Behav; 2021 Apr; 117():107814. PubMed ID: 33611102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends of anti-seizure medication use in pediatric patients in six cities in China from 2013 to 2018.
    Yu L; Feng J; Yu Z; Dai H
    Epilepsy Res; 2020 Nov; 167():106448. PubMed ID: 32916644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy, tolerability and safety of levetiracetam therapy in a pediatric population.
    Tekgül H; Gencpinar P; Çavuşoğlu D; Dündar NO
    Seizure; 2016 Mar; 36():16-21. PubMed ID: 26874856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initial levetiracetam versus valproate monotherapy in antiseizure medicine (ASM)-naïve pediatric patients with idiopathic generalized epilepsy with tonic-clonic seizures.
    Abdelmesih SK; Elkhateeb N; Zakaria M; Girgis MY
    Seizure; 2021 Oct; 91():263-270. PubMed ID: 34246881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrospective study of the use of levetiracetam in childhood seizure disorders.
    Koukkari MW; Guarino EJ
    J Child Neurol; 2004 Dec; 19(12):944-7. PubMed ID: 15704867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and tolerability of levetiracetam for pediatric refractory epilepsy.
    Muramatsu K; Sawaura N; Ogata T; Makioka N; Tomita K; Motojima T; Ida K; Hazama K; Arakawa H
    Brain Dev; 2017 Mar; 39(3):231-235. PubMed ID: 27745925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levetiracetam monotherapy in children with epilepsy: Experience from a tertiary pediatric neurology center.
    Yıldırım M; Bektaş Ö; Akıncı Göktaş Ö; Yüksel MF; Şahin S; Tıraş Teber S
    Epilepsy Behav; 2021 Mar; 116():107745. PubMed ID: 33508749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and tolerability of levetiracetam during 1-year follow-up in patients with refractory epilepsy.
    Ben-Menachem E; Gilland E
    Seizure; 2003 Apr; 12(3):131-5. PubMed ID: 12651076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of Levetiracetam Monotherapy in Pediatric Patients With Epilepsy.
    Mazur RD; Wang Ba Q; Kato Bs K; Buchsbaum Bs R; Bonito Bs J; Choi H; Hirsch L; Detyniecki K
    J Child Neurol; 2019 Sep; 34(10):593-597. PubMed ID: 31113283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is the anticonvulsant activity of levetiracetam dose-dependent?
    Lamouret V; Kurth C; Intravooth T; Steinhoff BJ
    Seizure; 2020 Dec; 83():197-202. PubMed ID: 33197757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experience with levetiracetam in childhood epilepsy].
    Neuwirth M; Saracz J; Hegyi M; Paraicz E; Kollár K; Móser J; Rosdy B; Herczegfalvi A; Fogarasi A
    Ideggyogy Sz; 2006 May; 59(5-6):179-82. PubMed ID: 16786712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levetiracetam monotherapy for the treatment of infants with epilepsy.
    Arican P; Gencpinar P; Cavusoglu D; Olgac Dundar N
    Seizure; 2018 Mar; 56():73-77. PubMed ID: 29453114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An open-label study of levetiracetam at individualised doses between 1000 and 3000 mg day(-1) in adult patients with refractory epilepsy.
    Abou-Khalil B; Hemdal P; Privitera MD
    Seizure; 2003 Apr; 12(3):141-9. PubMed ID: 12651078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levetiracetam in refractory pediatric epilepsy.
    Wheless JW; Ng YT
    J Child Neurol; 2002 Jun; 17(6):413-5. PubMed ID: 12174960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of adjunctive levetiracetam therapy in pediatric intractable epilepsy.
    Lee YJ; Kang HC; Kim HD; Lee JS
    Pediatr Neurol; 2010 Feb; 42(2):86-92. PubMed ID: 20117743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term efficacy and safety of lacosamide and levetiracetam monotherapy in elderly patients with focal epilepsy: A retrospective study.
    Del Bianco C; Placidi F; Liguori C; Mari L; Ulivi M; Ornello R; Pisani A; Mercuri NB; Izzi F
    Epilepsy Behav; 2019 May; 94():178-182. PubMed ID: 30959275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levetiracetam in children with refractory epilepsy: a multicenter open label study in Germany.
    Opp J; Tuxhorn I; May T; Kluger G; Wiemer-Kruel A; Kurlemann G; Gross-Selbeck G; Rating D; Brandl U; Bettendorf U; Härtel C; Korn-Merker E
    Seizure; 2005 Oct; 14(7):476-84. PubMed ID: 16182573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levetiracetam monotherapy in children with epilepsy.
    Khurana DS; Kothare SV; Valencia I; Melvin JJ; Legido A
    Pediatr Neurol; 2007 Apr; 36(4):227-30. PubMed ID: 17437904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of Levetiracetam for Epilepsy in Pediatric Liver Transplant Recipients With Posterior Reversible Encephalopathy Syndrome.
    Sezer T; Balcı Sezer O; Özçay F; Akdur A; Torgay A; Haberal M
    Exp Clin Transplant; 2020 Jan; 18(Suppl 1):96-98. PubMed ID: 32008507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.